Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, ...

After striking a pact to bolster intravenous solution supplies in the U.S. last year, California's ICU Medical has run into a ...

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown ...

b IVP = i.v. push, IV = i.v. infusion over at least 60 minutes, SP = syringe-pump infusion over less than 40 minutes.

In 2023, infusion pumps accounted for the largest share of the home infusion therapy market, with over 45% of total revenue contribution. These pumps are widely used to administer controlled doses ...

The global injectable drug delivery devices market size is calculated at USD 565 billion in 2025 and is expected to reach around USD 1,217 billion by ...

Meropenem was provided as unreconstituted drug in the ADD-Vantage, Minibag Plus (Baxter Healthcare), and addEASE (McGaw) infusion systems. Although these systems help to overcome problems of ...

Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, pharmaceuticals and patient support systems to have driven recovery.

In 2023, infusion pumps accounted for the largest share of the home infusion therapy market, with over 45% of total revenue contribution. These pumps are widely used to administer controlled doses of ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...